ULTXF yields 20000.00% · PFE yields 6.13%● Live data
📍 ULTXF pulled ahead of the other in Year 1
Combined, ULTXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ULTXF + PFE for your $10,000?
Ultra Lithium Inc., a mineral exploration company, focuses on the development of advanced lithium and gold projects in Argentina, Canada, and the United States. It holds two types of lithium projects and 16 gold mining and exploration licences. The company focuses on Laguna Verde I Brine lithium property and Laguna Verde II Brine lithium property located in Argentina; and 13 gold mining licenses and three gold exploration licences situated in the Chepes area, Argentina, as well as Georgia Lake Pegmatites lithium project and Forgan Lake Pegmatites lithium project located in Ontario, Canada. The company was formerly known as Ultra Resources Inc. and changed its name to Ultra Lithium Inc. in January 2022. Ultra Lithium Inc. was incorporated in 2004 and is headquartered in Vancouver, Canada.
Full ULTXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.